On April 9, the governments of Venezuela and Russia signed an agreement that includes a robust professional training program, geared towards biotechnological autonomy, with technology transfer for the local production of insulin and other essential biological products for the public health system.

“The alliance between the Russian pharmaceutical company Geropharm and the Ministry of People’s Power for Health focuses on modernizing the Socialist Enterprise for the Production of Biological Medicines (Espromed BIO).”

The main objective of the agreement is to guarantee the supply of medicines, as well as to transform Venezuela into a regional biotechnology production center. The agreement will have two phases:

• Supply Guarantee: Direct import of ready-to-use insulin from St. Petersburg to meet the immediate demand of the public healthcare system.
• Technology Transfer: Adaptation and modernization of Espromed BIO’s installations for the independent manufacturing of vials, cartridges, and injection pens within Venezuela.

“Beyond infrastructure, the agreement includes a robust professional training program. Specialists from both countries have already begun refresher seminars at the Latin American School of Medicine (ELAM), addressing critical topics such as integrated diabetes management and the use and application of biosimilar medications.”

M.Pino

Source: radiomiraflores

(Reference image source: CDC on Unsplash)

Follow our news on Google! For current, interesting, and accurate information, click here to see all the content on Bitfinance.news. You can also find us on X/Twitter and Instagram

La entrada Venezuela and Russia sign pharmaceutical cooperation agreement apareció primero en Bitfinance.

The president of the Venezuelan Chamber of Pharmacies (Cavefar), Alicia Pinedo, reported a 10 % year-on-year increase in national drug consumption in February.

Pinedo noted that 85 % of the drugs consumed in the country are domestically manufactured, emphasizing that “most of the drugs sold are generics, which are primarily sold by independent pharmacies.”

She highlighted the success of generic products, as customers obtain a cheaper product with the same quality.

The president of Cavefar has participated in working groups with representatives of the national government and the Vice Presidency of Science, Technology, and Health on topics such as the supply of essential medicines, health oversight, and digitalization to automate all procedures, ensuring traceability and prompt response.

M.Pino

Source: bancaynegocios

(Reference image source: Árpád Czapp on Unsplash)

Follow our news on Google! For current, interesting, and accurate information, click here to see all the content on Bitfinance.news. You can also find us on X/Twitter and Instagram

La entrada Cavefar reports 10 % increase in national drug consumption apareció primero en Bitfinance.